Articles on this page are updated by ProfileData Research on an hourly basis. To see the summary of the SENS notice, please click on the headline. To read the original SENS message, please click on the link in the summary.
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
Archive
Date
Headline/Title
09 December 2021
Report on Annual General Meeting proceedings
03 December 2021
Renewal of Cautionary Announcement – API Business
30 November 2021
Aspen confirms Non-binding Term Sheet on manufacture and sale of an Aspen branded COVID-19 vaccine throughout Africa
29 November 2021
Cautionary announcement – Discussions to conclude COVID-19 Licensing Agreement
23 November 2021
Broad-Based Black Economic Empowerment Certificate
09 November 2021
Appointment of Dr Yvonne Muthien as independent Non-executive director
28 October 2021
Confirmation of release of Integrated Report and further notice of AGM to be held on 9 December 2021
27 October 2021
Dealing in securities by Directors, Company Secretary and Prescribed Officers of the company
27 October 2021
Vesting and delayed delivery of securities for Directors, Company Secretary and Prescribed Officers of the Company
22 October 2021
Divestment of a portfolio of six South African products to Acino
21 October 2021
Renewal of Cautionary Announcement – API Business
04 October 2021
No Change Statement and Notice of Annual General Meeting – 9 December 2021
09 September 2021
Cautionary Announcement – API Business
03 September 2021
Changes to the board and its committees – Retirement of Sindi Zilwa
01 September 2021
Aspen final results June 2021
25 August 2021
Aspen’s results for the year ended 30 June 2021 and results presentation
05 August 2021
Changes to the Board – Appointment of Sean Capazorio as Executive Director and Group Chief Financial Officer
26 July 2021
Aspen confirms release of COVID-19 vaccines to Johnson & Johnson for supply to South Africa
01 July 2021
Final Completion of the Divestment of the European Thrombosis Business to Mylan/Viatris
30 June 2021
Aspen secures new financing package
24 June 2021
Illustrative historic revenue information
14 June 2021
Aspen Statement on Manufacture and Supply of COVID-19 Vaccines
31 May 2021
Aspen Pledges its Support of Equitable Vaccine Access in Africa
11 March 2021
Aspen interim results December 2020
04 March 2021
Amended release date of Aspen’s Interim Results for the six months ended 31 December 2020 and Results Presentation
04 March 2021
Release date of Aspen’s Interim Results for the six months ended 31 December 2020 and Results Presentation
01 March 2021
Aspen’s Interim Results for the six months ended 31 December 2020 and Results presentation
23 February 2021
Trading Statement
10 February 2021
Gus Attridge to step down at end of 2021
10 February 2021
European Commission’s acceptance of Aspen’s commitments to address the preliminary assessment regarding pricing
Powered by
ProfileData